EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

First-trimester serum hepcidin as an early predictor of preeclampsia: A prospective cohort study

A.A. Mohammed, Z.A.A. Fatnan, T.K. Lafta, H.A. Abass

Репродуктивная медицина (Центральная Азия) · 01.10.2026 · (3) · 203-211

DOI: 10.37800/rm.3.2026.858 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Репродуктивная медицина (Центральная Азия), online erschienen am 01.10.2026. Verfasst von A.A. Mohammed und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relevance: Preeclampsia remains one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Hepcidin, the “master regulator” of iron homeostasis, is upregulated by inflammatory stimuli involved in preeclampsia pathophysiology, but its predictive value remains controversial. The study aimed to assess the predictive utility of first-trimester serum hepcidin, C-reactive protein, and ferritin for preeclampsia. Materials and Methods: This prospective cohort study included pregnant women at 9-13 weeks of gestation. Of 345 women approached, 45 declined or had early pregnancy loss, leaving 300 women followed through delivery. Serum hepcidin, C-reactive protein (CRP), and ferritin were measured at recruitment; participants were classified as having no, mild, or severe preeclampsia.

Results

Of the 300 women, 40 (13.3%) developed preeclampsia (30 mild, 10 severe). First-trimester hepcidin was significantly higher in women who later developed preeclampsia (29.28 ± 13.49 vs 14.75 ± 8.66 ng/mL, p < 0.001) and increased with severity (mild: 26.63 ± 11.70; severe: 37.22 ± 15.95 ng/mL; p < 0.001). Hepcidin correlated with CRP overall (r = 0.153, p = 0.008) and more strongly within the preeclampsia group (r = 0.625, p < 0.001). Hepcidin’s area under the curve (AUC) was 0.804, similar to CRP (0.799) and higher than ferritin (0.700); the combined model reached an AUC of 0.839. After adjustment for maternal age, BMI, gravidity, parity, and gestational age at sampling, hepcidin remained independently associated with preeclampsia (adjusted OR = 1.06, 95% CI 1.01-1.11, p = 0.010; adjusted model AUC = 0.90).

Conclusion

First-trimester serum hepcidin is significantly elevated in women who subsequently develop preeclampsia and tends to be higher in severe disease; this association is not dependent on maternal age, BMI, gravidity, parity, or gestational age at sampling. Hepcidin shows predictive performance comparable to CRP and, combined with other markers, may aid early risk stratification for preeclampsia.

Zitieren

APA

Mohammed, A., Fatnan, Z., Lafta, T., & Abass, H. (2026). First-trimester serum hepcidin as an early predictor of preeclampsia: A prospective cohort study. Репродуктивная медицина (Центральная Азия), 203-211. https://doi.org/10.37800/rm.3.2026.858

Vancouver

Mohammed A, Fatnan Z, Lafta T, Abass H. First-trimester serum hepcidin as an early predictor of preeclampsia: A prospective cohort study. Репродуктивная медицина (Центральная Азия). 2026:203-211. doi:10.37800/rm.3.2026.858

BibTeX
@article{Mohammed2026,
  author = {Mohammed, A.A. and Fatnan, Z.A.A. and Lafta, T.K. and Abass, H.A.},
  title = {First-trimester serum hepcidin as an early predictor of preeclampsia: A prospective cohort study},
  journal = {Репродуктивная медицина (Центральная Азия)},
  year = {2026},
  number = {3},
  pages = {203--211},
  doi = {10.37800/rm.3.2026.858}
}
Kostenlos starten →